| Rheumatoid Arthritis |
1 |
1 |
| Thromboembolism |
0 |
0.9 |
| Biologic Therapy |
0 |
0.76 |
| Pulmonary Embolism |
0 |
0.67 |
| Disease-Modifying Antirheumatic Drugs |
0 |
0.6 |
| Deep Venous Thrombosis |
0 |
0.57 |
| Match |
0 |
0.53 |
| Medical Life |
0 |
0.52 |
| Medicare |
0 |
0.45 |
| Arthritis |
0 |
0.3 |
| Hospital |
0 |
0.3 |
| Venous Thromboembolism (VTE) |
0 |
0.99 |
| Brachial |
0 |
0.15 |
| California |
0 |
0.15 |
| Embolism |
0 |
0.15 |
| Immunomodulator |
0 |
0.15 |
| Nebraska |
0 |
0.15 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.15 |
| Pharmacoeconomics |
0 |
0.15 |
| Pharmacoepidemiology |
0 |
0.15 |
| Student Health and Well-Being |
0 |
0.15 |
| Students |
0 |
0.15 |
| Thrombosis |
0 |
0.15 |
| Vein |
0 |
0.15 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.13 |
| HIV Infection |
0 |
0.13 |